04:23 PM EDT, 08/05/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) reported a Q2 net loss late Tuesday of $0.95 per diluted share, widening from the loss of $0.39 a year earlier.

Analysts polled by FactSet expected a loss of $0.83.

Revenue in the three months ended June 30 rose to $110.6 million from $2.17 million a year earlier.

Analysts surveyed by FactSet expected $88 million.

Shares of BridgeBio Pharma ( BBIO ) fell 11% in after-hours trading.